Plasma copeptin concentration is a predictor of tolvaptan efficacy in patients with hepatic ascites

Plasma copeptin concentration is a predictor of tolvaptan efficacy in patients with hepatic ascites

Abstract Aims No solid evidence‐based opinion was raised regarding predictors of the degree of ascites reduction with tolvaptan. This retrospective cohort study aimed to examine whether serum copeptin concentration is a useful predictor of this. Methods The study population consisted of 80 patients...

Full description

Bibliographic Details
Main Authors: Fumimasa Tomooka, Kei Moriya, Takahiro Kubo, Akihiko Shibamoto, Jyunya Suzuki, Satoshi Iwai, Soichi Takeda, Yuki Fujimoto, Masahide Enomoto, Koji Murata, Yuki Tsuji, Yukihisa Fujinaga, Koh Kitagawa, Norihisa Nishimura, Hiroaki Takaya, Kosuke Kaji, Hideto Kawaratani, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Portal Hypertension & Cirrhosis
Subjects:
ascites
copeptin
decompensated liver cirrhosis
diuretics
tolvaptan
Online Access:https://doi.org/10.1002/poh2.55

Internet

https://doi.org/10.1002/poh2.55

Similar Items